These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9394648

  • 1. Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions.
    Burtscher IM, Ståhlberg F, Holtås S.
    Acta Radiol; 1997 Nov; 38(6):953-60. PubMed ID: 9394648
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
    Porto L, Hattingen E, Stuecher A, Herminghaus S, Lanfermann H, Ulrich Pilatus UP.
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A, Braun C, Skardelly M, Paulsen F, Schittenhelm J, Ernemann U, Bisdas S.
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [Abstract] [Full Text] [Related]

  • 7. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
    Zeng Q, Liu H, Zhang K, Li C, Zhou G.
    Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions].
    Ando K, Ishikura R, Nagami Y, Morikawa T, Takada Y, Ikeda J, Nakao N, Matsumoto T, Arita N.
    Nihon Igaku Hoshasen Gakkai Zasshi; 2004 Mar; 64(3):121-6. PubMed ID: 15148787
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH.
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The value of proton MR-spectroscopy in the differentiation of brain tumours from non-neoplastic brain lesions.
    Aydin H, Sipahioğlu S, Oktay NA, Altin E, Kizilgöz V, Hekimoglu B.
    JBR-BTR; 2011 Apr; 94(1):1-10. PubMed ID: 21466053
    [Abstract] [Full Text] [Related]

  • 18. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
    Wald LL, Nelson SJ, Day MR, Noworolski SE, Henry RG, Huhn SL, Chang S, Prados MD, Sneed PK, Larson DA, Wara WM, McDermott M, Dillon WP, Gutin PH, Vigneron DB.
    J Neurosurg; 1997 Oct; 87(4):525-34. PubMed ID: 9322843
    [Abstract] [Full Text] [Related]

  • 19. Preoperative magnetic resonance spectroscopy improves diagnostic accuracy in a series of neurosurgical dilemmas.
    Rao PJ, Jyoti R, Mews PJ, Desmond P, Khurana VG.
    Br J Neurosurg; 2013 Oct; 27(5):646-53. PubMed ID: 23461752
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.